Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Coopervision, Inc.
- Enrollment
- 103
- Locations
- 2
- Primary Endpoint
- Comfort Preference
Study Overview
Brief Summary
The objective of the study is to compare the overall subjective comfort profile over 8 hours of lens wear in two groups of habitual soft contact lens wearers (daily disposable hydrogel lenses and frequent replacement lenses) when refitted in to somofilcon A lenses.
Detailed Description
This will be a prospective, single day, randomized, double-masked, non-dispensing, contralateral study. Participants were recruited into one of two groups - participants who habitually wore etafilcon A: daily disposable hydrogel lenses and participants who habitually wore frequent replacement lenses (FREQ).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 17 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •A person is eligible for inclusion in the study if he/she:
- •Is at least 17 years of age and has full legal capacity to volunteer;
- •Has read and signed an information consent letter;
- •Is willing and able to follow instructions and maintain the appointment schedule;
- •Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual correction or the assigned study lenses;
- •Habitually wears either etafilcon A lens or any frequent replacement contact lenses (as defined in 4.1.1);
- •Habitually wear contact lenses with a power between -1.00 and -6.00D (Diopters) (inclusive) in both eyes;
- •Demonstrates an acceptable fit with the study lenses;
- •Is usually able to wear contact lenses for at least 8 hours per day.
Exclusion Criteria
- •A person will be excluded from the study if he/she:
- •Is participating in any concurrent clinical or research study;
- •Has any known active* ocular disease and/or infection;
- •Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- •Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- •Has known sensitivity to the diagnostic substances (pharmaceuticals), such as fluorescein dye, or products to be used in the study;
- •Is aphakic;
- •Has undergone refractive error surgery.
- •Has participated in the previous somfofilcon A study (ORE# 20893)
- •For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
Arms & Interventions
Etafilcon A (control)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
Intervention: somofilcon A (test) (Device)
Etafilcon A (control)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
Intervention: etafilcon A (control) (Device)
Somofilcon A (test)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
Intervention: etafilcon A (control) (Device)
Somofilcon A (test)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
Intervention: somofilcon A (test) (Device)
Outcomes
Primary Outcomes
Comfort Preference
Time Frame: Baseline and 8 hours
Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens
Limbal Hyperemia
Time Frame: Baseline and 8 hours
Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
Conjunctival Staining
Time Frame: 8 hours
Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas: N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central
Visual Acuity
Time Frame: Baseline and 8 hours
High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.
Comfort
Time Frame: 8 hours
Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.
Bulbar Hyperemia
Time Frame: Baseline and 8 hours
Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
Secondary Outcomes
No secondary outcomes reported